2024
|
Invention
|
Composition containing influenza vaccine.
The present invention provides a composition comprisin... |
|
Invention
|
Method for producing retinal tissues.
The present invention aims to provide a method for suppres... |
|
Invention
|
Cell-accommodating dish and kit for administering cells. Provided is a cell-accommodating dish fr... |
|
Invention
|
Process for preparing optically-active azabicyclo ring derivative, and intermediate for its produ... |
|
Invention
|
Magnetic particles used for medication management. The present disclosure provides magnetic parti... |
|
Invention
|
Cannula. The present invention addresses the problem of providing a cannula excellent in terms of... |
|
Invention
|
Antisense oligonucleotide capable of regulating expression and/or function of rps25 gene. Provide... |
|
Invention
|
Composition for inducing immune tolerance. The present invention provides a composition for induc... |
|
Invention
|
Anti-influenza antibody. The present application provides a monoclonal antibody, or an antibody f... |
|
Invention
|
Clinical trial site selection and interactive visualization.
A method comprising retrieving a pl... |
|
Invention
|
Conjugate of dextran and tlr7 agonist. The present invention relates to a conjugate of a TLR7 ago... |
|
Invention
|
Clinical trial site selection and interactive visualization. A method comprising retrieving a plu... |
|
Invention
|
Method for producing retinal tissue. The present disclosure is a method for producing a retinal t... |
|
Invention
|
Therapeutic drug for retinal pigment epithelium tears. The purpose of the present invention is to... |
|
Invention
|
Transplantation of pituitary hormone-producing cells. The present invention provides a therapeuti... |
|
Invention
|
Pyrimidine compound.
The present invention provides a compound of the formula (1):
The present... |
|
Invention
|
Method for producing retinal tissue. The present disclosure includes: a method for producing a re... |
|
Invention
|
Optically active azabicyclo ring derivative.
The compound of formula (1a) wherein p is 1 or 2, R... |
2023
|
Invention
|
Method for producing dopaminergic neuron progenitor cell.
A cell population comprising Corin- an... |
|
Invention
|
Combination use of wt1 antigen peptide and immunomodulator.
The invention relates to a combinati... |
|
Invention
|
Therapeutic agent for bacterial infection. The present disclosure provides a medicament and curin... |
|
G/S
|
Pharmaceutical preparations; cells for medical use. |
|
G/S
|
Pharmaceutical preparations for the central nervous system; cells for medical use |
|
G/S
|
Pharmaceutical preparations; cells for medical use. |
|
Invention
|
Nitrogen-containing saturated heterocyclyl derivative. 6 is hydrogen, halogen, etc., X is oxygen,... |
|
Invention
|
Information processing device, system, program, and method for inferring diagnosis-related inform... |
|
Invention
|
Bicyclic pyridine derivative. The present disclosure provides bicyclic pyridine derivatives.
A c... |
|
Invention
|
Radioactive pharmaceutical composition. The present invention pertains to a liquid pharmaceutical... |
|
Invention
|
Method for evaluating quality of retinal implant. The purpose of the present invention is to prov... |
|
Invention
|
Management of psychiatric or mental conditions using digital reality with cognitive behavioral te... |
|
Invention
|
Chatbot module facilitating insight evaluation and multi-sourced response generation.
A system c... |
|
Invention
|
Chatbot module facilitating insight evaluation and multi-sourced response generation. A system co... |
|
Invention
|
Oxidative cleavage method of trolox amide. The present disclosure provides an oxidative cleavage ... |
|
Invention
|
Granules for suspension. The present disclosure provides granules for suspension. Specifically, t... |
|
Invention
|
Self degradation-type cdk9 inhibitor prodrug and liposome encapsulating same.
Provided is a self... |
2022
|
G/S
|
Computer software; computer software and applications for
providing, analyzing and generating re... |
|
Invention
|
Determination method for a psychiatric disorder, program, determination device for a psychiatric ... |
|
Invention
|
Production method for sheet-like retinal tissue.
The present disclosure provides a method for ma... |
|
Invention
|
Cell aggregate including pituitary hormone-producing cells and method for producing same.
The pr... |
|
Invention
|
Method for producing cell mass including pituitary tissue and cell mass.
The present invention a... |
|
G/S
|
Calculating machines, data processing equipment, computers; downloadable computer software for da... |
|
G/S
|
Calculating machines, data processing equipment, computers;
computer software; computer software... |
|
Invention
|
Epitope peptide of human alpha-synuclein and pharmaceutical composition including said peptide.
... |
|
Invention
|
Method for producing cerebral cortical cell preparation derived from human pluripotent stem cells... |
|
Invention
|
Transplant material and kidney transplant kit.
A transplant material used for kidney xenotranspl... |
|
Invention
|
Phenyl urea derivative.
The present invention relates to a medicament for treating or preventing... |
|
Invention
|
Method for producing retinal tissue.
An object of the present invention is to provide a method f... |
|
Invention
|
Radioactive antitumor agent.
The present invention aims to provide a Actinium-225-labeled anti-M... |
|
Invention
|
Humanised antibodies labelled with radionuclides that emit beta-rays.
The present invention aims... |
|
Invention
|
Bicyclic pyridine derivative.
The present disclosure provides bicyclic pyridine derivatives.
T... |
|
G/S
|
Chemical additives for use in the manufacture of food, cosmetics and pharmaceuticals; Humectants;... |
|
Invention
|
Prediction of amount of in vivo dopamine etc., and application thereof.
The present disclosure p... |
|
Invention
|
Method for producing fusion protein.
A method for producing a fusion protein containing BDNF and... |
|
Invention
|
Method for producing cysteine knot protein.
A method for producing a cysteine knot protein, the ... |
2021
|
Invention
|
Therapy based on synthetic lethality in swi/snf complex-dysfunction cancer.
The present disclosu... |
|
Invention
|
Oral solid preparation.
The present invention relates to an oral solid dosage form comprising N2... |
|
G/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
G/S
|
Pharmaceutical preparations. |
2019
|
Invention
|
Therapeutic drug for disease accompanied by disorders in retinal cells or retinal tissue.
The pr... |